Long-term results of first salvage treatment in CLL patients treated initially with FCR (fludarabine, cyclophosphamide, rituximab)

Although fludarabine, cyclophosphamide, and rituximab (FCR) together are established as a standard first-line treatment of younger patients with chronic lymphocytic leukemia (CLL), there is little information to guide the management of patients with CLL refractory to, or who have relapsed after, rec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood
Autors principals: Tam, Constantine S., O’Brien, Susan, Plunkett, William, Wierda, William, Ferrajoli, Alessandra, Wang, Xuemei, Do, Kim-Anh, Cortes, Jorge, Khouri, Issa, Kantarjian, Hagop, Lerner, Susan, Keating, Michael J.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2014
Matèries:
Clinical Trials and Observations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4231417/
https://ncbi.nlm.nih.gov/pubmed/25281606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2014-06-583765
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars